South Africa - back to square one on device regulation
This article was originally published in Clinica
South Africa's new law regulating medical products, which was passed by mistake earlier this year, has been set aside by the high court in Pretoria.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.